Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
A Comparison of PAM50 Intrinsic Subtyping with Immunohistochemistry and Clinical Prognostic Factors in Tamoxifen-Treated Estrogen Receptor–Positive Breast Cancer
2010542 citationsTorsten O. Nielsen, Joel S. Parker et al.Clinical Cancer Researchprofile →
This map shows the geographic impact of Jerry P. Reed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jerry P. Reed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jerry P. Reed more than expected).
This network shows the impact of papers produced by Jerry P. Reed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jerry P. Reed. The network helps show where Jerry P. Reed may publish in the future.
Co-authorship network of co-authors of Jerry P. Reed
This figure shows the co-authorship network connecting the top 25 collaborators of Jerry P. Reed.
A scholar is included among the top collaborators of Jerry P. Reed based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Jerry P. Reed. Jerry P. Reed is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
A Comparison of PAM50 Intrinsic Subtyping with Immunohistochemistry and Clinical Prognostic Factors in Tamoxifen-Treated Estrogen Receptor–Positive Breast Cancer breakdown →
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.